NP

Nikhil Prabhakar Pathankar

Active Director Director DIN 11533273
DIN 11533273 First appointment Feb 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Nikhil Prabhakar Pathankar

Data last updated:

Nikhil Prabhakar Pathankar is a Director at Vidharbha Remedies Private Limited (since 2026). The company operates in Pharma.

DIN 11533273
Primary Designation Director
Industry Pharma
First Appointment 09 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vidharbha Remedies Private Limited U47720MH2026PTC467809
Director09 Feb 20262026Active

Board colleagues of Nikhil Prabhakar Pathankar

NameDINCompanyDesignation
Pallavi Namdevravji Mohale11533272Vidharbha Remedies Private LimitedDirector

Directorship timeline

Open interactive timeline →
Vidharbha Remedies Private Limited
Premium access

Shareholding and investment profile for Nikhil Prabhakar Pathankar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nikhil Prabhakar Pathankar

Nikhil Prabhakar Pathankar currently holds 1 directorship: Vidharbha Remedies Private Limited (Director, since 09 Feb 2026).

Nikhil Prabhakar Pathankar was first appointed on 09 Feb 2026 as Director at Vidharbha Remedies Private Limited.

The current boards of Nikhil Prabhakar Pathankar's companies include Pallavi Namdevravji Mohale (Vidharbha Remedies Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available